QGEP Participacoes SA (QGEP3):企業の財務・戦略的SWOT分析

◆英語タイトル:QGEP Participacoes SA (QGEP3) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14583
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ブラジル
◆産業分野:石油・ガス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥44,400見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
QGEP Participacoes SA (QGEP), a subsidiary of Queiroz Galvao Group, is an oil and gas company that explores, develops and produces oil and gas properties. The company’s exploration properties include Santos Basin, Espirito Santo Basin, Camamu-Almada Basin, Sergipe-Alagoas Basin, Pernambuco-Paraiba Basin, Ceara Basin, Para-Maranhao Basin, and Foz do Amazonas Basin. It also explores and produces hydrocarbon reserves. QGEP’s development assets comprise Atlanta and Oliva fields, and Camarao Norte Basin. It also carries out tests in order to verify the reserve estimates and to support the production curve. The company conducts production and discovery activities in Manati field. QGEP is headquartered in Rio de Janeiro, Brazil.

QGEP Participacoes SA Key Recent Developments

Nov 12,2018: Solstad enters into contract with QGEP for CSV ”Normand Pioneer”
Oct 11,2018: QGEP announces relinquishment of Camarao Norte discovery
Sep 17,2018: QGEP Announces Contracting of Laguna Star drillship for the Atlanta Field
Sep 11,2018: QGEP announces relinquishment of two blocks in Pernambuco-Paraiba basin
Aug 08,2018: QGEP updates production guidance for the Atlanta Field

This comprehensive SWOT profile of QGEP Participacoes SA provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of QGEP Participacoes SA including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

QGEP Participacoes SA – Key Information
QGEP Participacoes SA – Overview
QGEP Participacoes SA – Key Employees
QGEP Participacoes SA – Key Employee Biographies
QGEP Participacoes SA – Key Operational Heads
QGEP Participacoes SA – Major Products and Services
QGEP Participacoes SA – History
QGEP Participacoes SA – Company Statement
QGEP Participacoes SA – Locations And Subsidiaries

Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

QGEP Participacoes SA – Business Description
QGEP Participacoes SA – Corporate Strategy
QGEP Participacoes SA – SWOT Analysis
SWOT Analysis – Overview
QGEP Participacoes SA – Strengths
QGEP Participacoes SA – Weaknesses
QGEP Participacoes SA – Opportunities
QGEP Participacoes SA – Threats
QGEP Participacoes SA – Key Competitors

Section 3 – Company Financial Performance Charts

QGEP Participacoes SA – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

QGEP Participacoes SA, Key Information
QGEP Participacoes SA, Key Ratios
QGEP Participacoes SA, Share Data
QGEP Participacoes SA, Major Products and Services
QGEP Participacoes SA, History
QGEP Participacoes SA, Key Employees
QGEP Participacoes SA, Key Employee Biographies
QGEP Participacoes SA, Key Operational Heads
QGEP Participacoes SA, Other Locations
QGEP Participacoes SA, Subsidiaries

QGEP Participacoes SA, Key Competitors
QGEP Participacoes SA, SWOT Analysis
QGEP Participacoes SA, Ratios based on current share price
QGEP Participacoes SA, Annual Ratios
QGEP Participacoes SA, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

QGEP Participacoes SA, Performance Chart
QGEP Participacoes SA, Ratio Charts

★海外企業調査レポート[QGEP Participacoes SA (QGEP3):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Re-Vana Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Re-Vana Therapeutics Ltd (Re-Vana) is an ocular pharmaceutical and drug delivery company that develops and commercialization of biodegradable long- acting drug delivery platforms to treat ophthalmic conditions. The company provides drug delivery products such as OcuLief, an injectable platfo …
  • Bilim Pharmaceuticals:企業の戦略的SWOT分析
    Bilim Pharmaceuticals - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Grant Thornton International Ltd:企業の戦略的SWOT分析
    Grant Thornton International Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Oberbank AG:企業の戦略・SWOT・財務分析
    Oberbank AG - Strategy, SWOT and Corporate Finance Report Summary Oberbank AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • AMEWAS, Inc.:企業の戦略・SWOT・財務情報
    AMEWAS, Inc. - Strategy, SWOT and Corporate Finance Report Summary AMEWAS, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Marksans Pharma Ltd (MARKSANS):製薬・医療:M&Aディール及び事業提携情報
    Summary Marksans Pharma Ltd (Marksans Pharma) is a pharmaceutical company that develops, manufactures and markets branded formulations and generic products. The company manufactures non-sterile liquids, ointments and powder products. It offers solid oral dosage in form of tablets, hard gelatin capsu …
  • The Gunma Bank Ltd
    The Gunma Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary The Gunma Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Amdocs Limited:企業の戦略・SWOT・財務情報
    Amdocs Limited - Strategy, SWOT and Corporate Finance Report Summary Amdocs Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Copenhagen Infrastructure Partners KS:電力:M&Aディール及び事業提携情報
    Summary Copenhagen Infrastructure Partners KS (CIP) is a fund management service provider. The company provides structuring, executing and managing investments within energy infrastructure. It invests in energy infrastructure assets including offshore wind, onshore wind, offshore power transmission, …
  • Lloyds Banking Group Plc:企業のM&A・事業提携・投資動向
    Lloyds Banking Group Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Lloyds Banking Group Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Suzano Papel e Celulose SA (SUZB5):企業の財務・戦略的SWOT分析
    Suzano Papel e Celulose SA (SUZB5) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Probiogen AG:企業のM&A・事業提携・投資動向
    Probiogen AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Probiogen AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Carondelet Health Network-製薬・医療分野:企業M&A・提携分析
    Summary Carondelet Health Network (Carondelet) is a healthcare service organization that serves through its network of hospitals including St. Mary’s Hospital, St. Joseph’s Hospital and Holy Cross Hospital. The organization provides a wide range of medical and treatment services such as neurology or …
  • Hemanext:医療機器:M&Aディール及び事業提携情報
    Summary Hemanext, formerly New Health Sciences Inc, is a medical technology company that develops blood storage systems. The company offers an anaerobic storage system that minimizes oxidative damage to red blood cells in storage and delivers physiologic, therapeutic, and fresher red blood cell than …
  • Aurigene Discovery Technologies Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Aurigene Discovery Technologies Ltd (Aurigene), a subsidiary of Dr. Reddy's Laboratories Ltd, is a biotechnology company that develops small molecule and peptide therapeutics. The company develops small molecule and peptide drug candidates for oncology and inflammatory diseases. It owns inte …
  • TE Connectivity Ltd (TEL):企業の財務・戦略的SWOT分析
    TE Connectivity Ltd (TEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Cellectis SA (ALCLS):製薬・医療:M&Aディール及び事業提携情報
    Summary Cellectis SA (Cellectis) is a clinical-stage biopharmaceutical company that research, develop and commercialise rational genome engineering technologies. The company pioneers gene editing company, deploying core proprietary technologies to develop off-the-shelf immunotherapies to target and …
  • Sujana Universal Industries Ltd. (SUJANAUNI):企業の財務・戦略的SWOT分析
    Sujana Universal Industries Ltd. (SUJANAUNI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …
  • bioMerieux SA (BIM):医療機器:M&Aディール及び事業提携情報
    Summary bioMerieux SA (bioMerieux), a subsidiary of Institut Merieux SA, develops, manufactures and markets in vitro diagnostic solutions for private and hospital laboratories. The company offers diagnostic solutions such as systems, reagents and software. Its products are used to diagnose infectiou …
  • Cleveland BioLabs Inc (CBLI):企業の財務・戦略的SWOT分析
    Summary Cleveland BioLabs Inc (Cleveland) is a bio pharmaceutical company that develops and commercializes drugs to treat cancer, orphan indications and protect healthy tissues from radiation and chemotherapy. The company’s product includes entolimod, a recombinant protein that acts as an agonist of …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆